5afh: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==alpha7-AChBP in complex with lobeline== | ==alpha7-AChBP in complex with lobeline== | ||
<StructureSection load='5afh' size='340' side='right' caption='[[5afh]], [[Resolution|resolution]] 2.40Å' scene=''> | <StructureSection load='5afh' size='340' side='right' caption='[[5afh]], [[Resolution|resolution]] 2.40Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=L0B:ALPHA-LOBELINE'>L0B</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=L0B:ALPHA-LOBELINE'>L0B</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5afj|5afj]], [[5afk|5afk]], [[5afl|5afl]], [[5afm|5afm]], [[5afn|5afn]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5afj|5afj]], [[5afk|5afk]], [[5afl|5afl]], [[5afm|5afm]], [[5afn|5afn]]</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5afh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5afh OCA], [http://www.rcsb.org/pdb/explore.do?structureId=5afh RCSB], [http://www.ebi.ac.uk/pdbsum/5afh PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5afh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5afh OCA], [http://pdbe.org/5afh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5afh RCSB], [http://www.ebi.ac.uk/pdbsum/5afh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5afh ProSAT]</span></td></tr> | ||
</table> | </table> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| Line 15: | Line 16: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
<div class="pdbe-citations 5afh" style="background-color:#fffaf0;"></div> | |||
==See Also== | |||
*[[Acetylcholine binding protein|Acetylcholine binding protein]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 05:00, 11 March 2017
alpha7-AChBP in complex with lobelinealpha7-AChBP in complex with lobeline
Structural highlights
Publication Abstract from PubMedThe alpha7 nicotinic acetylcholine receptor (nAChR) belongs to the family of pentameric ligand-gated ion channels and is involved in fast synaptic signaling. In this study, we take advantage of a recently identified chimera of the extracellular domain of the native alpha7 nicotinic acetylcholine receptor and acetylcholine binding protein, termed alpha7-AChBP. This chimeric receptor was used to conduct an innovative fragment-library screening in combination with X-ray crystallography to identify allosteric binding sites. One allosteric site is surface-exposed and is located near the N-terminal alpha-helix of the extracellular domain. Ligand binding at this site causes a conformational change of the alpha-helix as the fragment wedges between the alpha-helix and a loop homologous to the main immunogenic region of the muscle alpha1 subunit. A second site is located in the vestibule of the receptor, in a preexisting intrasubunit pocket opposite the agonist binding site and corresponds to a previously identified site involved in positive allosteric modulation of the bacterial homolog ELIC. A third site is located at a pocket right below the agonist binding site. Using electrophysiological recordings on the human alpha7 nAChR we demonstrate that the identified fragments, which bind at these sites, can modulate receptor activation. This work presents a structural framework for different allosteric binding sites in the alpha7 nAChR and paves the way for future development of novel allosteric modulators with therapeutic potential. Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the alpha7 nicotinic acetylcholine receptor.,Spurny R, Debaveye S, Farinha A, Veys K, Vos AM, Gossas T, Atack J, Bertrand S, Bertrand D, Danielson UH, Tresadern G, Ulens C Proc Natl Acad Sci U S A. 2015 Apr 27. pii: 201418289. PMID:25918415[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||